Chad Estis and Bill Rhoda have been handed expanded executive roles by Legends, part of the company's reorganizing after its ...

Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.